About Index Trending news
Analyze
Pricing
Amgen Inc.

Amgen Inc.

Work at Amgen Inc.? Add yourself to this profile

Amgen Inc.

Amgen engages in the development of human therapeutic products in supportive ofcancer care, inflammation, nephrology and bone diseases.
Edit Profile
More info

Elsewhere

Contributors to this profile

Companies in the same industry

AgeneBio AgeneBio Bioheart Bioheart Entelos Entelos Morphogen-IX Morphogen-IX LAM Therapeutics LAM Therapeutics Emerus Hospital Partners Emerus Hospital Partners GLO Science GLO Science InSite Vision InSite Vision Molplex Molplex Laurantis Pharma Laurantis Pharma

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 8

Portfolio

Acquisitions 4

Apps 1
Add info
Science 37

Science 37

Health Care Information Technology
Total funding
$66.5M in 3 rounds from 12 investors
By Amgen Ventures
$29M Series C in Apr, 2017
Akili Interactive

Akili Interactive

Health Care +1
Total funding
$42.4M in 2 rounds from 5 investors
By Amgen Ventures
$11.9M Series B in Jul, 2016
miRagen Therapeutics

miRagen Therapeutics

Biotechnology +2
Total funding
$60.5M in 4 rounds from 18 investors
By Amgen Ventures
$8.5M Series C in Feb, 2015
Integrated Diagnostics

Integrated Diagnostics

Health Care +2
Total funding
$95.2M in 8 rounds from 18 investors
By Amgen Ventures
undisclosed deal in Jul, 2005
Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc.

Biotechnology
Total funding
$52M in 2 rounds from 13 investors
By Amgen Ventures
$13.5M Series B in Jan, 2014
Alector

Alector

Biotechnology
Total funding
$29.5M in 1 rounds from 9 investors
By Amgen Ventures
$29.5M Series D in Jan, 2016
Tizona Therapeutics

Tizona Therapeutics

Therapeutics
Total funding
$43M in 1 rounds from 7 investors
By Amgen Ventures
$43M Series B in Mar, 2016

Want to see the complete list?
Go Pro!